EUVIMEDEUVIMED entdecken
Crossref

Repurposing of Mitotane an Anticancer Agent as Anti- Platelet Agent for Ischemic Heart Disease Treatment

Seema Khot, Nilesh Bhosale, Wasim Shaikh, Gajanan Daphal, Vaibhav Changediya, Babaso Udugade

International Journal of Drug Delivery Technology · 25.12.2025 · 15 (04)

DOI: 10.25258/ijddt.15.4.25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.12.2025. Verfasst von Seema Khot und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research investigates the application of mitotane, currently approved by the FDA for adrenocortical carcinoma treatment, as a potential anti-platelet drug targeting ischemic heart disease (IHD). This is because, IHD has been identified as a growing problem, and the current antiplatelet agents are always limited either by resistance or the risk of bleeding. Hence the quest for alternatives to these therapies. Antiplatelet drug repurposing was performed with a ligand-based approach that used computational structural comparison of these compounds with mitotane and clopidogrel bisulphate. DrugRep bake-off results indicated that mitotane has a binding score of 0.294 to the protein 4PY0, which suggest potential effects in platelet aggregation, but not related to the formation of clots. Docking studies revealed that mitotane formed significant contacts with several amino acids located in the docking site. The present study espouses the benefits of drug repurposing and encourages more clinical trials evaluation studies on the efficacy of mitotane in Ischemic Heart Disease Treatment.

Zitieren

APA

Khot, S., Bhosale, N., Shaikh, W., Daphal, G., Changediya, V., & Udugade, B. (2025). Repurposing of Mitotane an Anticancer Agent as Anti- Platelet Agent for Ischemic Heart Disease Treatment. International Journal of Drug Delivery Technology, 15(04). https://doi.org/10.25258/ijddt.15.4.25

Vancouver

Khot S, Bhosale N, Shaikh W, Daphal G, Changediya V, Udugade B. Repurposing of Mitotane an Anticancer Agent as Anti- Platelet Agent for Ischemic Heart Disease Treatment. International Journal of Drug Delivery Technology. 2025;15(04). doi:10.25258/ijddt.15.4.25

BibTeX
@article{Khot2025,
  author = {Khot, Seema and Bhosale, Nilesh and Shaikh, Wasim and Daphal, Gajanan and Changediya, Vaibhav and Udugade, Babaso},
  title = {Repurposing of Mitotane an Anticancer Agent as Anti- Platelet Agent for Ischemic Heart Disease Treatment},
  journal = {International Journal of Drug Delivery Technology},
  year = {2025},
  volume = {15},
  number = {04},
  doi = {10.25258/ijddt.15.4.25}
}
Kostenlos starten →